Description
Buy Selank — research-grade anxiolytic and nootropic heptapeptide (TP-7), ≥99% HPLC-verified purity, US-manufactured, batch-specific COA included. Selank is studied for GABA-A modulation, BDNF expression, and neuroimmune regulation without sedation or dependence.
What Is Selank?
Selank (sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro) is a synthetic heptapeptide derived from the naturally occurring immunomodulatory peptide tuftsin, extended with a Pro-Gly-Pro stabilizing sequence to dramatically extend the molecule’s plasma half-life. Developed at the Institute of Molecular Genetics of the Russian Academy of Sciences and approved in Russia since 2009, it remains one of the most extensively documented anxiolytic peptides outside the benzodiazepine class and a staple reference compound in short-peptide CNS research.
Researchers buy Selank to investigate an unusual anxiolytic profile: it modulates GABA-A receptor function in a manner analogous to benzodiazepines, yet preclinical models consistently show no sedation, no tolerance development, no cognitive impairment, and no physical dependence after chronic dosing. For a deeper overview, see our Selank research guide and related Semax vs Selank comparison.
Because Selank crosses the blood-brain barrier efficiently and tolerates intranasal, subcutaneous, and intraperitoneal delivery in animal models, it has become a practical tool peptide for groups studying stress-response biology, learning and memory, neuroimmune crosstalk, and novel anxiolytic mechanisms without the confounders that benzodiazepine comparators introduce.
Key Research Applications
- Anxiolytic research: Non-sedating GABA-A modulation and stress-response models across elevated plus maze, open field, Vogel conflict, and social defeat paradigms.
- Nootropic studies: BDNF-mediated neuroplasticity, memory consolidation, attention, and cognitive resilience under stress.
- Neuroimmune axis: Cytokine modulation, tuftsin-derived immunomodulation, and neuroinflammatory models.
- Combination peptide research: Synergy studies pairing Selank with Semax for anxiolytic-nootropic endpoints.
- Monoamine interaction: Serotonin metabolism and dopamine turnover in cortical and limbic regions.
- Chronic administration safety: Long-duration dosing without tolerance or withdrawal markers.
Product Specifications
| Peptide | Selank (TP-7) |
| CAS Number | 129954-34-3 |
| Sequence | Thr-Lys-Pro-Arg-Pro-Gly-Pro |
| Amount | 1 vial (research quantity) |
| Purity | ≥99% (third-party HPLC and mass spectrometry) |
| Form | Lyophilized white powder |
| Storage | Lyophilized: <-20°C long-term. Reconstituted: 2–8°C, use within 30 days. |
| Testing | Batch-specific COA included |
| Origin | US manufactured |
Reviews
There are no reviews yet.